AlphaStocks

AZN vs FSS

As of Sep 20, 2026, Astrazeneca (AZN) scores 5.0/10 and Federal Signal (FSS) 5.6/10 on AlphaStocks' five-model composite, so FSS scores higher. AZN trades 14% below its model fair value; FSS trades 8% above its model fair value.

AZN

ASTRAZENECA PLC

5.0

Consider Buy

$166.29

FSS

FEDERAL SIGNAL CORP /DE/

5.6

Consider Buy

$113.93

AZN vs FSS: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 5.0/10 while FEDERAL SIGNAL CORP /DE/ (FSS) scores 5.6/10 on AlphaStocks' composite model. FEDERAL SIGNAL CORP /DE/ has the higher composite rating of Consider Buy. On a P/E basis, ASTRAZENECA PLC trades at 25.4x, making it the more attractively priced of the two. ASTRAZENECA PLC trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricAZNFSS
Scores & Fundamentals
Composite Score5.0/105.6/10
RatingConsider BuyConsider Buy
Price$166.29$113.93
P/E Ratio25.428.4
ROE21.9%18.2%
Market Cap$260B$7B
Fair Value$192.63$105.60
Dividend Yield1.9%
Sector Rank#111 of 168#63 of 265
Model Verdicts
PiotroskiStrongAttractive
BuffettStrongStrong
GrahamCautionNeutral
LynchNeutralNeutral
GreenblattNeutralAttractive
View full AZNanalysis →View full FSSanalysis →

Related comparisons

Compare any two stocks →

AZN vs FSS: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) is in the Health Care sector; FEDERAL SIGNAL CORP /DE/ (FSS) is in Industrials. FSS currently leads with a composite score of 5.6/10 (Consider Buy) compared to AZN's 5.0/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer